Navigation Links
Grifols Establishes Expert Advisory Council in Transfusion Medicine

BARCELONA, Spain, March 7, 2011 /PRNewswire/ -- Grifols, a global healthcare company and biopharmaceutical manufacturer based in Barcelona, Spain today announced that it has established an Expert Advisory Council in Transfusion Medicine drawing on the expertise of internationally renowned physicians and researchers from across the globe.  The role of the Expert Advisory Council is to provide insight, advice and guidance to Grifols' own transfusion medicine research and development activities.


"Bringing together these leaders in transfusion medicine underscores our longstanding commitment to being a world leader in blood diagnostics and transfusion medicine," said Eva Bastida, Ph.D, Scientific Director of Grifols. "Working with this team of experts will bring new perspectives to shape our strategic goals and plans," continued Dr. Bastida.  Grifols Diagnostics is focused on the development of cutting-edge technologies for use in clinical laboratories and blood banks.

"It is an honor to serve with my transfusion medicine colleagues on the Grifols Expert Advisory Council," said Mr. John Moulds, MT (ASCP) director of Scientific Support Services at LifeShare Blood Centers, Shreveport, Louisiana who serves as the Council Chair.  "Working with such a highly esteemed group of thought leaders will no doubt bear fruit that will help shape future directions in transfusion medicine," stated Mr. Moulds.  

Grifols has a seventy-year history of advancing blood diagnostics and transfusion medicine remains a core part of its business today.  With input from the Expert Advisory Council Grifols will continue to advance its mission of improving hemovigilance, transfusion safety, and the quality of life for people who receive blood transfusions.  The broad geographic diversity of Advisory Council members is expected to stimulate creative new approaches to current transfusion medicine challenges.  

Grifols portfolio of products and services cover every link of the transfusion chain: blood bags and donation kits, blood component separators, autoanalyzers and reagents for pre-transfusion analytical tests (blood typing and donor-recipient compatibility studies) and blood bank management software, among others.

Members of the Advisory CouncilThe Advisory Council is chaired by Mr. John Moulds, MT (ASCP) director of Scientific Support Services at LifeShare Blood Centers,  Shreveport, Louisiana, USA, and its membership consists of nine globally respected experts from different countries.  Members of the Grifols Advisory Council on Transfusion Medicine include:Dr. Jill R. Storry, Ph.D.Docent / Assoc. ProfessorKIT / Clinical Immunology and Transfusion Medicine Labmedicin Skane University and Regional Laboratories Lund - SWEDENProf. Dr. Lilian Castilho, PhDCoordinator, Blood Center of CampinasCEP Campinas SP  - BRAZILDr. Miquel Lozano, MD, PhDChief of the Hemotherapy Section of the Department of Hemotherapy and Hemostasis, Hospital Clinic of Barcelona, Barcelona, Spain.Dr. Arthur Bracey, MDMedical Director, Transfusion ServicesSt. Luke's Episcopal HospitalHouston, TX - USProf. W. John Judd, FIBMS, MIBiolPresident and CEOImmunohematology Consulting, LLCSupply, NC - USDr. Mark Yazer, MD FRCPCAssociate Professor of Pathology, University of PittsburghMedical Director, RBC Serology Reference Laboratory, Centralized Transfusion Service, The Institute for Transfusion MedicinePittsburgh, PA US Dr. Yoshihiko Tani, MD, PhDJapanese Red Cross Osaka Blood Center - JAPANProf. Neil AventHead of School School of Biomedical and Biological SciencesUniversity of Plymouth, Plymouth, UKDr. Jacques  Chiaroni Directeur de l'Etablissement Francais du Sang Alpes-MediterraneeMarseille, FRANCEAbout GrifolsGrifols is a Spanish holding company, specializing in the hospital-pharmaceutical sector, and with a presence in over 90 countries. Since May 2006 Grifols has been listed on the Spanish Continuous Market, and has been included in the Ibex-35 since 2008.  Grifols focuses on the research, development, manufacture and marketing of plasma products, diagnostic systems, intravenous therapies, enteral nutrition and medical supplies.  In recent years Grifols has made significant investments in the area of transfusion medicine to advance its mission of improving hemovigilance, transfusion safety, and the quality of life for people who receive blood transfusions.  For more information visit


SOURCE Grifols
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Health Robotics CytoCare(TM) Global Expansion Continues With Grifols International in Latin America
2. AMDL Diagnostics, Inc. Enters Into Exclusive Distribution Agreement With Grifols USA, LLC to Advance Commercialization of DR-70 Onko-Sure(TM) Cancer Test
3. Grifols Agrees to Acquire Intellectual Property for Treatment of Post-Polio Syndrome From Pharmalink AB
4. Health Robotics CytoCare Continues European Expansion With Grifols and Vall dHebron University Hospital
5. NASDAQ Removes TLCR From Biotechnology Index Pending FTC Decision on Grifols Acquisition
6. Grifols Starts Construction of a New Plasma Fractionation Plant in Barcelona (Parets Del Valles)
7. Grifols Signs Cooperative Agreement for Commercialization of Immunohematology Diagnostic Products in the US
8. Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay
9. Transgenomic Establishes Collaboration With the National Cancer Institute to Investigate Mitochondrial Genome and Associated Nuclear Genes in Cancer Cell Lines
10. Pharmaxis Establishes Named Patient Program for Bronchitol
11. First Candidate from Esperances Targeted Anti-cancer Platform, EP-100, Establishes Preclinical Proof of Concept
Post Your Comments:
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):